Clinical Trial Detail

NCT ID NCT00838955
Title Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Loyola University
Indications

Hodgkin's lymphoma

Therapies

Temsirolimus

Age Groups: adult

No variant requirements are available.